BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27623947)

  • 21. Genetic variants affecting incretin sensitivity and incretin secretion.
    Müssig K; Staiger H; Machicao F; Häring HU; Fritsche A
    Diabetologia; 2010 Nov; 53(11):2289-97. PubMed ID: 20714888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms.
    Campbell JE
    Mol Metab; 2021 Apr; 46():101139. PubMed ID: 33290902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incretin hormones in the treatment of type 2 diabetes. Part I: influence of insulinotropic gut-derived hormones (incretins) on glucose metabolism].
    Matuszek B; Lenart-Lipińska M; Nowakowski A
    Endokrynol Pol; 2007; 58(6):522-8. PubMed ID: 18205109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study.
    Abbas S; Linseisen J; Rohrmann S; Beulens JW; Buijsse B; Amiano P; Ardanaz E; Balkau B; Boeing H; Clavel-Chapelon F; Fagherazzi G; Franks PW; Gavrila D; Grioni S; Kaaks R; Key TJ; Khaw KT; Kühn T; Mattiello A; Molina-Montes E; Nilsson PM; Overvad K; Quirós JR; Rolandsson O; Sacerdote C; Saieva C; Slimani N; Sluijs I; Spijkerman AM; Tjonneland A; Tumino R; van der A DL; Zamora-Ros R; Sharp SJ; Langenberg C; Forouhi NG; Riboli E; Wareham NJ
    Eur J Clin Nutr; 2014 Feb; 68(2):196-202. PubMed ID: 24253760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA; Bergmann NC; Knop FK
    Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
    Yabe D; Seino Y
    Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variation in the glucose-dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2 diabetes in the Malmo Diet and Cancer cohort.
    Sonestedt E; Lyssenko V; Ericson U; Gullberg B; Wirfält E; Groop L; Orho-Melander M
    J Clin Endocrinol Metab; 2012 May; 97(5):E810-8. PubMed ID: 22399504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants of TCF7L2 gene and its coherence with metabolic parameters in Lithuanian (Kaunas district) women population with previously diagnosed gestational diabetes mellitus compared to general population.
    Francaite-Daugeliene M; Lesauskaite V; Tamosiunas A; Jasukaitiene A; Velickienė D
    Diabetes Res Clin Pract; 2021 Feb; 172():108636. PubMed ID: 33352264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the interaction between transcription factor 7-like 2 genetic variants with nopal and wholegrain fibre intake: effects on anthropometric and metabolic characteristics in type 2 diabetes patients.
    López-Ortiz MM; Garay-Sevilla ME; Tejero ME; Perez-Luque EL
    Br J Nutr; 2016 Sep; 116(6):969-78. PubMed ID: 27480250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study.
    ; Bendinelli B; Palli D; Masala G; Sharp SJ; Schulze MB; Guevara M; van der AD; Sera F; Amiano P; Balkau B; Barricarte A; Boeing H; Crowe FL; Dahm CC; Dalmeijer G; de Lauzon-Guillain B; Egeberg R; Fagherazzi G; Franks PW; Krogh V; Huerta JM; Jakszyn P; Khaw KT; Li K; Mattiello A; Nilsson PM; Overvad K; Ricceri F; Rolandsson O; Sánchez MJ; Slimani N; Sluijs I; Spijkerman AM; Teucher B; Tjonneland A; Tumino R; van den Berg SW; Forouhi NG; Langeberg C; Feskens EJ; Riboli E; Wareham NJ
    Diabetologia; 2013 Jan; 56(1):47-59. PubMed ID: 22983636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes remission after bariatric surgery: is it just the incretins?
    Laferrère B
    Int J Obes (Lond); 2011 Sep; 35 Suppl 3(0 3):S22-5. PubMed ID: 21912382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Reduced Incretin Effect Mediated by the rs7903146 Variant in the
    Galderisi A; Tricò D; Pierpont B; Shabanova V; Samuels S; Dalla Man C; Galuppo B; Santoro N; Caprio S
    Diabetes Care; 2020 Oct; 43(10):2553-2563. PubMed ID: 32788279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of incretin on diabetes mellitus.
    Sanusi H
    Acta Med Indones; 2009 Oct; 41(4):205-12. PubMed ID: 20737753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of incretin receptors genetic polymorphisms with type 2 diabetes mellitus in Egyptian patients.
    Shalaby SM; Zidan HE; Shokry A; Saeed J; El-Sokkary RH
    J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28744963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
    Pathak V; Vasu S; Flatt PR; Irwin N
    Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incretins and microRNAs: Interactions and physiological relevance.
    Radbakhsh S; Sathyapalan T; Banach M; Sahebkar A
    Pharmacol Res; 2020 Mar; 153():104662. PubMed ID: 31982487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.